. Author manuscript; available in PMC: 2017 Jun 14.

Published in final edited form as: Eur J Pharmacol. 1993 Nov 16;249(3):271–280. doi: 10.1016/0014-2999(93)90522-j

TABLE 1.

Locomotor effect (horizontal activity ± S.E.M.) of chronic administration of CPA, CPX, and vehicle. CPA (20 μg/kg), CPX (1.0 mg/kg) and vehicle injected for 9 days prior to testing followed by concurrent testing and administration.

Analysis of variance showed no significant drug effect in any group. Horizontal activity: [F(l,16)= 0.001, Ρ > 0.05)].

	Day 1	Day 2	Day 3	Day 4	Day 5	Day 6	Day 7	Day 8
Vehicle	431/72	319/32	315/38	354/66	379/46	345/53	371/30	410/35
CPA	371/38	389/45	354/65	309/57	400/45	450/22	369/46	312/48
CPX	420/37	429/47	348/32	382/34	322/47	328/39	271/47	343/38